Published in
American Association for the Advancement of Science, Science Immunology, 61(6), 2021
DOI: 10.1126/sciimmunol.abh3634
Links
Tools
A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates
Journal article published in 2021 by
Maria Pino 
,
Talha Abid ,
Susan Pereira Ribeiro ,
Venkata Viswanadh Edara ,
Katharine Floyd ,
Justin C. Smith ,
Muhammad Bilal Latif,
Gabriela Pacheco-Sanchez ,
Debashis Dutta ,
Shelly Wang ,
Sanjeev Gumber,
Shannon Kirejczyk ,
Joyce Cohen ,
Rachelle L. Stammen,
Sherrie M. Jean
and other authors.
,
Talha Abid ,
Susan Pereira Ribeiro ,
Venkata Viswanadh Edara ,
Katharine Floyd ,
Justin C. Smith ,
Muhammad Bilal Latif,
Gabriela Pacheco-Sanchez ,
Debashis Dutta ,
Shelly Wang ,
Sanjeev Gumber,
Shannon Kirejczyk ,
Joyce Cohen ,
Rachelle L. Stammen,
Sherrie M. Jean
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
An adjuvanted monomeric RBD immunogen induces immunogenicity and protective immunity against SARS-CoV-2 in rhesus macaques.